Cargando…

Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing

Membrane bound mucins are up-regulated and aberrantly glycosylated during malignant transformation in many cancer cells. This results in a negatively charged glycoprotein coat which may protect cancer cells from immune surveillance. However, only limited data have so far demonstrated the critical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Madsen, Caroline B., Lavrsen, Kirstine, Steentoft, Catharina, Vester-Christensen, Malene B., Clausen, Henrik, Wandall, Hans H., Pedersen, Anders Elm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765166/
https://www.ncbi.nlm.nih.gov/pubmed/24039759
http://dx.doi.org/10.1371/journal.pone.0072413
_version_ 1782283238443581440
author Madsen, Caroline B.
Lavrsen, Kirstine
Steentoft, Catharina
Vester-Christensen, Malene B.
Clausen, Henrik
Wandall, Hans H.
Pedersen, Anders Elm
author_facet Madsen, Caroline B.
Lavrsen, Kirstine
Steentoft, Catharina
Vester-Christensen, Malene B.
Clausen, Henrik
Wandall, Hans H.
Pedersen, Anders Elm
author_sort Madsen, Caroline B.
collection PubMed
description Membrane bound mucins are up-regulated and aberrantly glycosylated during malignant transformation in many cancer cells. This results in a negatively charged glycoprotein coat which may protect cancer cells from immune surveillance. However, only limited data have so far demonstrated the critical steps in glycan elongation that make aberrantly glycosylated mucins affect the interaction between cancer cells and cytotoxic effector cells of the immune system. Tn (GalNAc-Ser/Thr), STn (NeuAcα2-6GalNAc-Ser/Thr), T (Galβ1–3GalNAc-Ser/Thr), and ST (NeuAcα2-6Galβ1–3GalNAc-Ser/Thr) antigens are recognized as cancer associated truncated glycans, and are expressed in many adenocarcinomas, e.g. breast- and pancreatic cancer cells. To investigate the role of the cancer associated glycan truncations in immune-mediated killing we created glyco-engineered breast- and pancreatic cancer cells expressing only the shortest possible mucin-like glycans (Tn and STn). Glyco-engineering was performed by zinc finger nuclease (ZFN) knockout (KO) of the Core 1 enzyme chaperone COSMC, thereby preventing glycan elongation beyond the initial GalNAc residue in O-linked glycans. We find that COSMC KO in the breast and pancreatic cancer cell lines T47D and Capan-1 increases sensitivity to both NK cell mediated antibody-dependent cellular-cytotoxicity (ADCC) and cytotoxic T lymphocyte (CTL)-mediated killing. In addition, we investigated the association between total cell surface expression of MUC1/MUC16 and NK or CTL mediated killing, and observed an inverse correlation between MUC16/MUC1 expression and the sensitivity to ADCC and CTL-mediated killing. Together, these data suggest that up-regulation of membrane bound mucins protects cells from immune mediated killing, and that particular glycosylation steps, as demonstrated for glycan elongation beyond Tn and STn, can be important for fine tuning of the immune escape mechanisms in cancer cells.
format Online
Article
Text
id pubmed-3765166
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37651662013-09-13 Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing Madsen, Caroline B. Lavrsen, Kirstine Steentoft, Catharina Vester-Christensen, Malene B. Clausen, Henrik Wandall, Hans H. Pedersen, Anders Elm PLoS One Research Article Membrane bound mucins are up-regulated and aberrantly glycosylated during malignant transformation in many cancer cells. This results in a negatively charged glycoprotein coat which may protect cancer cells from immune surveillance. However, only limited data have so far demonstrated the critical steps in glycan elongation that make aberrantly glycosylated mucins affect the interaction between cancer cells and cytotoxic effector cells of the immune system. Tn (GalNAc-Ser/Thr), STn (NeuAcα2-6GalNAc-Ser/Thr), T (Galβ1–3GalNAc-Ser/Thr), and ST (NeuAcα2-6Galβ1–3GalNAc-Ser/Thr) antigens are recognized as cancer associated truncated glycans, and are expressed in many adenocarcinomas, e.g. breast- and pancreatic cancer cells. To investigate the role of the cancer associated glycan truncations in immune-mediated killing we created glyco-engineered breast- and pancreatic cancer cells expressing only the shortest possible mucin-like glycans (Tn and STn). Glyco-engineering was performed by zinc finger nuclease (ZFN) knockout (KO) of the Core 1 enzyme chaperone COSMC, thereby preventing glycan elongation beyond the initial GalNAc residue in O-linked glycans. We find that COSMC KO in the breast and pancreatic cancer cell lines T47D and Capan-1 increases sensitivity to both NK cell mediated antibody-dependent cellular-cytotoxicity (ADCC) and cytotoxic T lymphocyte (CTL)-mediated killing. In addition, we investigated the association between total cell surface expression of MUC1/MUC16 and NK or CTL mediated killing, and observed an inverse correlation between MUC16/MUC1 expression and the sensitivity to ADCC and CTL-mediated killing. Together, these data suggest that up-regulation of membrane bound mucins protects cells from immune mediated killing, and that particular glycosylation steps, as demonstrated for glycan elongation beyond Tn and STn, can be important for fine tuning of the immune escape mechanisms in cancer cells. Public Library of Science 2013-09-06 /pmc/articles/PMC3765166/ /pubmed/24039759 http://dx.doi.org/10.1371/journal.pone.0072413 Text en © 2013 Madsen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Madsen, Caroline B.
Lavrsen, Kirstine
Steentoft, Catharina
Vester-Christensen, Malene B.
Clausen, Henrik
Wandall, Hans H.
Pedersen, Anders Elm
Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
title Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
title_full Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
title_fullStr Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
title_full_unstemmed Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
title_short Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
title_sort glycan elongation beyond the mucin associated tn antigen protects tumor cells from immune-mediated killing
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765166/
https://www.ncbi.nlm.nih.gov/pubmed/24039759
http://dx.doi.org/10.1371/journal.pone.0072413
work_keys_str_mv AT madsencarolineb glycanelongationbeyondthemucinassociatedtnantigenprotectstumorcellsfromimmunemediatedkilling
AT lavrsenkirstine glycanelongationbeyondthemucinassociatedtnantigenprotectstumorcellsfromimmunemediatedkilling
AT steentoftcatharina glycanelongationbeyondthemucinassociatedtnantigenprotectstumorcellsfromimmunemediatedkilling
AT vesterchristensenmaleneb glycanelongationbeyondthemucinassociatedtnantigenprotectstumorcellsfromimmunemediatedkilling
AT clausenhenrik glycanelongationbeyondthemucinassociatedtnantigenprotectstumorcellsfromimmunemediatedkilling
AT wandallhansh glycanelongationbeyondthemucinassociatedtnantigenprotectstumorcellsfromimmunemediatedkilling
AT pedersenanderselm glycanelongationbeyondthemucinassociatedtnantigenprotectstumorcellsfromimmunemediatedkilling